Testing effectiveness (Phase 2)Study completedNCT00618319
What this trial is testing
An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)
Who this might be right for
GIST
Biogen 20